BIOLASE, Inc., a global leader in dental lasers, recently invited clinicians and researchers from around the world to submit research proposals through a new portal. The company aims to increase the speed of submission, evaluation and acceptance of research projects that adds to the clinical evidence for laser technology, according to a news release.
"BIOLASE recognizes the importance of clinical research around the continued advancement of dental lasers and adoption of this breakthrough technology," said John Beaver, president and chief executive officer of BIOLASE, in the release. "Our new Research Grant Portal will allow us to evaluate and accept high-quality research proposals from all over the world and continue to demonstrate how BIOLASE lasers provide biologically and clinically superior performance with a more comfortable patient experience and faster recovery times."
BIOLASE has highlighted an interest in pediatric dentistry, endodontics, periodontics, implantology and photobiomodulation to advance its minimally invasive laser technology in these areas. In the past 30 years, BIOLASE has been part of hundreds of published articles and 302 issued and 31 pending patents for its technologies.
To learn more and apply visit: biolase.com/researchgrants.
News 28 October 2025
BIOLASE, the global leader in dental laser technology, will present a major advancement in periodontal care during the American Academy of Periodontology (AAP) 2025 Corporate Forum in Toronto,...
News 25 September 2025
BIOLASE, the global leader in dental laser technology, proudly announces a new chapter in its history following its acquisition by MegaGen Implant.
Products 20 December 2023
BIOLASE announced it has been awarded a Top Workplaces 2023 honor by Orange County Register Top Workplaces. The award is based solely on employee feedback gathered through a third-party survey...
Market 01 December 2022
Growth is expected due to demand for cosmetic dentistry and expansion of emerging markets worldwide.
News 28 November 2022
BIOLASE to participate in Benchmark Discovery One-on-One Investor Conference in NYC
President and CEO John Beaver and CFO Jennifer Bright will host one-on-one meetings with investors and analysts during the event.
Prosthodontics 17 November 2025
The purpose of this report is to describe a new technique to fabricate and deliver an implant-supported fixed prosthesis to the patient on the day of surgery, and to propose a protocol for the...
Editorials 17 November 2025
The Langkamp Allison Award recognizes a Pitt Dental Medicine third-year dental student interested in pursuing a career in dental education.
Products 17 November 2025
VELMENI today unveiled VELMENI Voice, an AI-driven voice recognition tool designed to transform periodontal charting and clinical documentation.
News 17 November 2025
Angelalign Technology Inc. (6699.HK) (“Angel”) recently announced the expansion of its flexible iOrtho platform to include direct integration with the Dexis, Shining 3D, and Panda scanners.
News 17 November 2025
Following the first FDA clearance for technology that measures internal mobility in teeth, Perimetrics CEO and Chairman Robert Hayman is once again leading dentistry into a new era with InnerView, a...